In NSCLC tumors, while MAGE-A3 and -A9 expression levels have been substantially linked with shorter survival times, few studies have looked at MAGE-A3 expression as a probable independent pointer of poor prognosis in NSCLC patients [16,17,18]. This evidence concerns the gene MAGEA3 and non-small cell lung carcinoma.